The effect of ligustrazine on the expression of CD44 in bone marrow of bone marrow transplantation mice / 中国实验血液学杂志
Journal of Experimental Hematology
;
(6): 278-281, 2004.
Artículo
en Chino
| WPRIM
| ID: wpr-352082
ABSTRACT
The aim of this study was to investigate the effects of ligustrazine on the expression of CD44 in bone marrow tissue at the early phase of hematopoietic reconstruction after bone marrow transplantation (BMT) in mice. The mice were divided into 3 groups normal mice without BMT treatment, BMT only and BMT added with ligustrazine groups. On the days 7, 14, 21, 28 after BMT, peripheral blood cells and bone marrow nucleated cells (BMNC) were counted, while the expression of CD44 was assayed by flow cytometry. CFU-S was determined on the day 10 after BMT. The results showed that in ligustrazine group the WBC, Plt and BMNC counts and hematopoietic tissue area estimation in bone marrow on the days 7, 14, 21, 28 after BMT were all higher than in BMT controlled group, CFU-S counts were higher than in BMT only group too. On the contrary, mature RBC volume was lower than in the BMT only group. The expression of CD44 in ligustrazine group on days 7, 14, 21, 28 after BMT was significantly higher than in BMT only group. It is concluded that ligustrazine can enhance CD44 expression in bone marrow of syngenic BMT mice, which may be one of mechanisms of ligustrazine accelerating hematopoietic reconstitution in bone marrow.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Patología
/
Farmacología
/
Pirazinas
/
Recuento de Células Sanguíneas
/
Médula Ósea
/
Química
/
Mortalidad
/
Trasplante de Médula Ósea
/
Receptores de Hialuranos
/
Hematopoyesis
Tipo de estudio:
Estudio pronóstico
Límite:
Animales
Idioma:
Chino
Revista:
Journal of Experimental Hematology
Año:
2004
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS